Bausch + Lomb (NYSE:BLCO) Price Target Raised to $19.00 at Evercore ISI

- Bausch + Lomb (NYSE:BLCO) Price Target Raised to $19.00 at Evercore ISI
Evercore ISI lifted their target price on Bausch + Lomb from $17.00 to $19.00 and gave the company an "in-line" rating in a research report...
from: MarketBeat

- Zimmer Biomet price target lowered to $110 from $113 at Evercore ISI
Evercore ISI analyst Vijay Kumar lowered the firm's price target on Zimmer Biomet to $110 from $113 and keeps an In Line rating on the...
from: TipRanks

- Stryker price target raised to $380 from $365 at Evercore ISI
Evercore ISI raised the firm's price target on Stryker to $380 from $365 and keeps an Outperform rating on the shares. In MedTech...
from: TipRanks

- Agilent price target raised to $145 from $135 at Evercore ISI
Evercore ISI analyst Vijay Kumar raised the firm's price target on Agilent to $145 from $135 and keeps an In Line rating on the shares.
from: TipRanks

- Intuitive Surgical price target raised to $475 from $410 at Evercore ISI
Evercore ISI analyst Vijay Kumar raised the firm's price target on Intuitive Surgical to $475 from $410 and keeps an In Line rating on the...
from: TipRanks

- Abbott price target raised to $124 from $120 at Evercore ISI
Evercore ISI raised the firm's price target on Abbott to $124 from $120 and keeps an Outperform rating on the shares. In MedTech...
from: TipRanks

- GE HealthCare price target raised to $102 from $98 at Evercore ISI
Evercore ISI raised the firm's price target on GE HealthCare to $102 from $98 and keeps an Outperform rating on the shares. In MedTech...
from: TipRanks

- Edwards Lifesciences price target lowered to $70 from $76 at Evercore ISI
Evercore ISI lowered the firm's price target on Edwards Lifesciences to $70 from $76 and keeps an In Line rating on the shares.
from: TipRanks

- Thermo Fisher price target raised to $630 from $605 at Evercore ISI
Evercore ISI analyst Vijay Kumar raised the firm's price target on Thermo Fisher to $630 from $605 and keeps an Outperform rating on the...
from: TipRanks

- Waters price target raised to $355 from $335 at Evercore ISI
Evercore ISI raised the firm's price target on Waters to $355 from $335 and keeps an In Line rating on the shares. In MedTech, utilization...
from: TipRanks